The synthetic biology market was valued at USD 22.47 billion, in 2018. The market is expected to register a growth rate of 34.91% over the forecast period. The primary drivers for the market include increasing support from government and private institutions and increasing R&D investments in drug discovery and development. Based on the product, the market was dominated by the enabled product in 2018. The fastest growing subsegment over the forecast period, under the product segmentation, was estimated to be enabled products. The enabled product sub-segment is expected to register a CAGR of 35.19% over the forecast period.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIESAND FUTURE TRENDS